Drug Delivery Systems

Committed to drug delivery excellence. Our vision is to enable customer success with high quality and innovative drug delivery solutions that improve patient well-being.

With over 50 years of experience, we are empowering customer success through innovative drug-delivery solutions that improve patient quality of life. Safety Pen Needles

Prefillable Syringes* (PFS) manufactured per year1

Products used by more than 500 Pharmaceutical and Biotechnology companies.2

BD customers include 27 of the top 30 pharmaceutical companies in the world.3

~70% of the top 100 pharmaceutical companies around the world rely BD Medical-Pharmaceutical Systems prefillable drug-delivery systems for a wide variety of therapeutic applications.4

BD has generated over 4000 patents that are enforced in more than 25 countries.5

There is a patient at the end of each of the billions of drug delivery devices that we make at BD. That is why we have invested in deep knowledge around patient experience, injection science and combination product development to anticipate customer challenges, manage complexities, and reduce risks. We also invest heavily to support our commitment to quality. Through our extensive global manufacturing network, we aim to offer security of supply and business continuity to our customers.

These, plus our ability to leverage the industry and health authority partnerships of a global healthcare company, are game changing advantages that BD brings to our customers’ drug delivery challenges.

We leverage these assets as we develop innovative solutions that provide peace of mind to customers and contribute to greater patient well-being.

Solutions to meet your needs across therapeutic areas

BD Medical - Pharmaceutical Systems manufactures and sells prefillable drug delivery systems to pharmaceutical and biotech companies.

BD uses proprietary needle technologies to develop needles that optimize your drug delivery.

Featuring a comprehensive portfolio of innovative prefillable syringe systems, BD offers drug delivery solutions designed to help decrease development risk, improve speed to market, and increase flexibility to meet patients’ needs across a wide range of drug types and therapeutic areas.

BD Safety & Shielding Systems provide pharmaceutical companies with a wide range of both active and passive manual injection solutions available in 0.5ml, 1ml, and 2.25ml formats, suitable for a variety therapeutic indications.

BD offers an extensive portfolio of patient centric, self-administered drug delivery solutions including disposable autoinjectors, disposable variable dose pen injectors, and wearable injectors designed to deliver a wide range of volumes and viscosities and help de-risk combination product development.

To fulfill our system approach, we provide a complete set of components for your prefillable syringe systems.

BD Effivax™ Glass Prefillable Syringe

BD SCF™ PremiumCoat® Plunger Stopper

BD Neopak™ XtraFlow™ Glass Prefillable Syringe

BD Hylok™ Glass Prefillable Syringe

BD Neopak™ XSi™ Glass Prefillable Syringe

BD Hypak™ for Vaccines Glass Prefillable Syringe

BD UltraSafe Plus™ 1mlL Passive Needle Guard

BD Sterifill Advance™ 50ml Polymer Prefillable Syringe

BD Neopak™ Glass Prefillable Syringe

BD acquires Safety Syringes Inc.

BD AutoShield Duo™ Safety Pen Needle

BD Hypak™ for Biotech Glass Prefillable Syringe

BD Hypak Physiolis™ Glass Prefillable Syringe

BD Sterifill™ Polymer Prefillable Syringe

BD Eclipse™ Needle Shielding System

BD Accuspray™ Nasal Spray System

BD SCF™ FluroTec® Plunger Stoppers

BD Uniject™ Auto-Disable Prefillable Injection System

BD Sterifill™ Polymer Prefillable Syringe

BD SafetyGlide™ Needle Shielding System

BD Hypak™ Glass Disposable Syringe

BD Physioject™ - recognized by the Arthritis Foundation®

BD Intevia™ - Best Practices Award

BD Libertas™ wins prestigious Good Design® Award

BD Libertas™ - Design Award

World’s Most Admired Companies

Fill out our form to have one of our experts contact you.

BDM-PS Financial file November 2022, “Actual FY22” Permiter.

BDM-PS Financial file November 2020, "Actual FY20" Permiter.

BD Customers compared to Evaluate Pharma ranking FY2019

IQVIA: IQVIA dataset extracted on March 11th, 2021, from the IQVIA Smart MIDAS' on-line platform, includes WW sales of injectable drugs. Top 100 Corporation (based on IQVIA standard units 2020) selling PFS, Autoinjectors or Pens. TA included: Acute biologics, Anticoagulants, Chronic, Small molecules, Vaccines

BDM-PS Patents – In force – Worldwide – October 2021.

Solutions to meet your needs across therapeutic areas

BD Medical - Pharmaceutical Systems manufactures and sells prefillable drug delivery systems to pharmaceutical and biotech companies.

BD uses proprietary needle technologies to develop needles that optimize your drug delivery.

To fulfill our system approach, we provide a complete set of components for your prefillable syringe systems.

Fill out our form to have one of our experts contact you.

BD understands the drug development process and objectives at each stage and offers a wide range of services to help develop container/device strategy and life cycle management plan for drugs.

BD Pharmaceutical Services and Solutions are designed to help you achieve your combination product goals, from development to launch.

BD PartnerPath™ Program aims to support pharmaceutical organizations that value speed to market in combination product development.1

We’ve built our services and capabilities around a deep understanding of the combination product development process and the key objectives at each stage, from discovery to delivery.

We are committed to partnering for your sustained commercial success.

Effective system integration can be critical to the success of combination products for pharmaceutical companies.1

We manufacture our solutions with a strict focus on continuously advancing quality, consistency and capacity.

Fill out our form to have one of our experts contact you.

View research articles published in a journal and written by experts sharing study results that offer you insight into a particular topic.

View a scientific poster, such as those used for display at BD tradeshows or seminars to provide detailed information on a research topic

Understand BD Products and services.

Learn more about order details, product specs, and technical information by viewing a brochure

Visit the BD Medical - Pharmaceutical Systems webinar portal

Watch a video to be educated about BD products or services

View promotions or announcements for BD products and services

Fill out our form to have one of our experts contact you.

Conference on Wearable Injectors and Connected Devices

BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency

BD Effivax™ Glass Prefillable Syringe Features Enhanced Technology that Builds on Company’s Decades of Expertise in the Prefillable Syringe Market and Supports Customers’ Manufacturing Needs FRANKLIN LAKES, N.J. (September 13, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination and integrity.1

BD and Mitsubishi Gas Chemical have signed a letter of intent (LOI) to discuss a partnership agreement to explore

Companies to work together with the aim of optimizing advanced technologies for use in prefillable syringes FRANKLIN LAKES, N.J. (May 18, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Mitsubishi Gas Chemical Company, Inc. (MGC), a R&D-oriented chemical manufacturer based in Tokyo, Japan, today announced that they have entered into an agreement to investigate further development of OXYCAPT™ - an innovation from MGC that integrates the best of plastic and glass for plastic syringes.

Fill out our form to have one of our experts contact you.